Skip to main content

Volume 3 Supplement 1

ESICM LIVES 2015

  • Poster presentation
  • Open access
  • Published:

Cerebral Autoregulation in Patients Treated With V-Vecmo For Severe Ards

Introduction

In patients with severe ARDS refractory to conventional mechanical ventilation, venous-venous extracorporeal membrane oxygenation (v-vECMO) is a rescue therapy able to restore normal values of PaO2 and PaCO2, maintaining the lung at rest. Hypoxemia and hypercapnia occurring in patients with severe ARDS may negatively affect cerebral autoregulation.

Objectives

The hypothesis of the present study was that, in patients with severe ARDS, impaired cerebral autoregulation due to gas exchange derangement, may be restored by application of v-vECMO.

Methods

Clinical prospective observational study. Inclusion criteria: severe ARDS (P/F ≤ 100), requiring v-vECMO. Exclusion criteria: previous diagnosed neurological diseases. the following parameters were recorded before (pre) and after institution of v-vECMO (post): mean arterial pressure (MAP), cerebral blood flow velocity in middle cerebral artery (MCA FV) by transcranial Doppler, and alveolar gas exchange (PaCO2, PaO2). Cerebral autoregulation was assessed by Pearson linear regression coefficient (Mx index) between MCA FV and MAP during spontaneous fluctuations of MAP (cut-off of Mx ≥ 0.2 was adopted to define impaired autoregulation).

Results

Five severe ARDS patients were enrolled. Three female with mean age of 40.2 ± 16.5, APACHE II 33 ± 6.4, SAPS II 60.4 ± 21.85, secondary to influenza H1N1 pneumonia (n = 3), cystic fibrosis (n = 1), pleural empyema (n = 1), duration of v-vECMO of 16 days (range 2-46). See Table 1.

Table 1 Physiological data before and after ECMO.

Patient 4 evolved to brain death on day 1 and was then excluded.

Paired t-test was used for analysis. MAP was 82 ± 9 and 94 ± 17, pre and post ECMO respectively. Mx significantly changed from 0.41 ± 0.2 to 0.13 ± 0.16 (p = 0.009); both PaO2 and PaCO2 significantly improved (p = 0.05).

Conclusions

In patients with severe ARDS our preliminary data suggest that v-vECMO is able to restore cerebral autoregulation that is impaired because of severe gas exchange derangement.

Author information

Authors and Affiliations

Authors

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fanelli, V., Mazzeo, A., Battaglini, I. et al. Cerebral Autoregulation in Patients Treated With V-Vecmo For Severe Ards. ICMx 3 (Suppl 1), A509 (2015). https://doi.org/10.1186/2197-425X-3-S1-A509

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/2197-425X-3-S1-A509

Keywords